Intercept Pharmaceuticals Inc. (ICPT) Fundamentals

Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor.
SHARE INFORMATION
Market Cap$ 573,316,500
Shares Outstanding41,127,439
Float32,430,569
Percent Float78.85%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 363,468,000
Latest Fiscal EPS$ -2.84
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions376
Institutional Holdings Date2022-09-30
Institutional Bought Previous 3 Months3,697,550
Institutional Holdings Percent108.2%
Institutional Sold Previous 3 Months3,324,549
Insider Holdings Date2022-09-30
Insider Bought Previous 3 Months-
Insider Holdings Percent3.8
Insider Sold Previous 3 Months4,511
Insider Shares Owned1,562,221
TRADING INFO
52 Week High$ 21.25
52 Week Low$ 10.81
52 Week High Change$ -3.06
21 Day Moving Average$ 16.03
21 Day Extended Moving Average$ 15.627
50 Day Moving Average$ 16.4668
50 Day Extended Moving Average$ 16.0348
200 Day Moving Average$ 15.9323
200 Day Extended Moving Average$ 16.5803
10 Day Average Volume1,557,134
20 Day Average Volume1,340,651
30 Day Average Volume1,160,973
50 Day Average Volume1,196,482
Alpha-0.013729
Beta1.1732
Standard Deviation0.191051
R20.102522
7 Day Price Change$ -2.47
7 Day Percent Change-15.05%
21 Day Price Change$ -3.63
21 Day Percent Change-20.66%
30 Day Price Change$ -2.38
30 Day Percent Change-14.58%
Month to Date Price Change$ -0.01
Month to Date Percent Change-0.07%
Quarter to Date Price Change$ -0.01
Quarter to Date Percent Change-0.07%
180 Day Price Change$ -3.89
180 Day Percent Change-21.82%
200 Day Price Change$ -2.64
200 Day Percent Change-15.92%
Year to Date Price Change$ -2.35
Year to Date Percent Change-14.43%

Intercept Pharmaceuticals Inc. (ICPT) Key Ratios

PROFITABILITY
EBIT Margin-8.2%
EBITDA Margin-7.8%
Pre-Tax Profit Margin-142.2%
Profit Margin Count-39.96%
Gross Margin99.2%
Profit Margin TOT-26.83%
INCOME STATEMENTS
Revenue$ 223,307,000
Revenue Per Share$ 5.4296
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-1.60
Total Debt To Equity0.00
Int Coverage-0.80
Current Ratio3.20
Leverage Ratio-1.30
Quick Ratio2.90
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-6.60
Enterprise Value$ 887,334,792
Price to Sales2.5674
Price to Free Cash-280.20
PE High Last 5 Years-4.70
Price To Book0.00
Price To Cash Flow152.70
PE Low Last 5 Years-5.20
Price to Tangible Book-1.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover7.00
Invoice Turnover0.00
Assets Turnover0.40
Return Assets-13.47
Return on Equity23.56
Return on Capital-49.87

Intercept Pharmaceuticals Inc. (ICPT) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG LLP
CEOJerome B. Durso
Emplyoees437
Last AuditUQ
CIK0001270073
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address10 Hudson Yards
37th Floor
New York, NY 10001
Websitehttps://www.interceptpharma.com
Facsimile-
Telephone+1 646 747-1000
Emailinvestors@interceptpharma.com


Your Recent History
NASDAQ
ICPT
Intercept ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.